Cargando…
Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
Vectored gene delivery of HIV-1 broadly neutralizing antibodies (bNAbs) using recombinant adeno-associated virus (rAAV) is a promising alternative to conventional vaccines for preventing new HIV-1 infections and for therapeutically suppressing established HIV-1 infections. Passive infusion of single...
Autores principales: | Lin, Allen, Balazs, Alejandro B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167872/ https://www.ncbi.nlm.nih.gov/pubmed/30285769 http://dx.doi.org/10.1186/s12977-018-0449-7 |
Ejemplares similares
-
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
por: Phelps, Meredith, et al.
Publicado: (2021) -
Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021) -
Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021) -
Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy
por: Lee, Suhwan, et al.
Publicado: (2019) -
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
por: Kashiwakura, Yuji, et al.
Publicado: (2022)